The present study was designed to test the hypothesis that the endothelial dysfunction associated with CAD and T2D occurs in parallel with increased mtROS production in the endothelium and that this, in turn, regulates endothelial AMPK activity. The gene discussed is PRKAA2; the disease is type 2 diabetes mellitus.